%0 Journal Article
%T Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
%A Aimee Hayes
%A Alexander Engel
%A Connie Diakos
%A Dale L Bailey
%A David LH Chan
%A Edward Hsiao
%A Elizabeth J Bernard
%A Enid Eslick
%A Geoffrey P Schembri
%A Jaswinder Samra
%A Mustafa Khasraw
%A Nick Pavlakis
%A Paul J Roach
%A Stephen J Clarke
%A Tristan Barnes
%J Theranostics
%D 2017
%I Ivyspring International Publisher
%R 10.7150/thno.18068
%X Background: PET scans using FDG and somatostatin receptor imaging agents have both been used to study neuroendocrine tumours. Most reports have documented the sensitivity and specificity of each radiopharmaceutical independently, and even suggested the superiority of one over the other for different grades of disease.
%K PET scans
%K Neuroendocrine tumour
%U http://www.thno.org/v07p1149.htm